Period of time： 2012年2期
Publisher： Adis International
Founded in： 1999
Total resources： 54
ISSN： 1174-5886
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Drugs in R,volume 5,issue 2
Menu
Access to resources
Recommend
Solifenacin Demonstrates High Absolute Bioavailability in Healthy Men
By Kuipers M.E., Krauwinkel W.J.J., Mulder H., Visser N. in (2004)
Drugs in R,volume 5,issue 2 , Vol. 5, Iss. 2, 2004-01 , pp.Calcitonin Intranasal Unigene: Salcatonin Intranasal - Unigene
By Adis International Limited in (2004)
Drugs in R,volume 5,issue 2 , Vol. 5, Iss. 2, 2004-01 , pp.By Adis International Limited in (2004)
Drugs in R,volume 5,issue 2 , Vol. 5, Iss. 2, 2004-01 , pp.Mitiglinide: KAD 1229, S 21403
By Adis International Limited in (2004)
Drugs in R,volume 5,issue 2 , Vol. 5, Iss. 2, 2004-01 , pp.Natalizumab: AN 100226, Anti-4 Integrin Monoclonal Antibody
By Adis International Limited in (2004)
Drugs in R,volume 5,issue 2 , Vol. 5, Iss. 2, 2004-01 , pp.Recombinant Human Antithrombin III: rhATIII
By Adis International Limited in (2004)
Drugs in R,volume 5,issue 2 , Vol. 5, Iss. 2, 2004-01 , pp.Rotavirus Vaccine AVANT Immunotherapeutics/GlaxoSmithKline: 89-12, RIX4414
By Adis International Limited in (2004)
Drugs in R,volume 5,issue 2 , Vol. 5, Iss. 2, 2004-01 , pp.By Adis International Limited in (2004)
Drugs in R,volume 5,issue 2 , Vol. 5, Iss. 2, 2004-01 , pp.By Adis International Limited in (2004)
Drugs in R,volume 5,issue 2 , Vol. 5, Iss. 2, 2004-01 , pp.